Biotech 2026: What Comes After a Breakthrough Year
2025 was not just another productive year for biotech. Multiple technologies reached new levels of practical impact. Here is what comes next.
Read breakdown →Delivery, safety, and clinical translation of programmable genome editing.
5 posts
2025 was not just another productive year for biotech. Multiple technologies reached new levels of practical impact. Here is what comes next.
Read breakdown →The hardest part of gene editing isn't the editing; it's getting the tools into the right cells. A new method triples efficiency.
Read breakdown →CRISPR therapies are now editing genes in real patients. The FDA approved the first one. What actually changes and what doesn't.
Read breakdown →Three wolf pups engineered to resemble extinct dire wolves. The biotech is impressive, but the "de-extinction" label deserves scrutiny.
Read breakdown →Colossal Biosciences created mice with mammoth-like fur. It's a proof of concept for de-extinction, and it raises real questions about whether we should.
Read breakdown →